$CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles$

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles

17 horas ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

4 horas ago

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

7 horas ago

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

8 horas ago

Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

9 horas ago

Diamond Comic Distributors Announces Change in Acquisition Partners

9 horas ago

$CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles$

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles

17 horas ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

4 horas ago

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

7 horas ago

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

8 horas ago

Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

9 horas ago

Diamond Comic Distributors Announces Change in Acquisition Partners

9 horas ago

$CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles$

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles

17 horas ago

Bienvenidos a Metro Latino USA, su portal de noticias.

ÚLTIMA HORA

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

26 de abril de 2025
NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

26 de abril de 2025
UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

26 de abril de 2025

Categorias

Actualidad (16240)
()
Comunidad (2810)
Entretenimiento (2683)
Deportes (1179)
DMV (1509)
Latin News (403)
Latinoamérica y Mundo (3733)
Maryland (1050)
Opinión (2901)
Virginia (891)

Metro Latino

Metro Latino USA

Metro Latino USA es un sitio informativo digital fundado en 2007 en el área de Washington, DC para crear conciencia ciudadana y sumarse a llamados a la acción con las nuevas plataformas disponibles online.

¡Síguenos!

¡Contáctenos!

[email protected]
www.metrolatinusa.com
Lun-Vier : 8:00 am - 5:00 pm

Opinión

En algún lugar… El ícono de los vicios

Si EE.UU. ataca a Irán, la supervivencia del ser humano puede estar en peligro

Estados Unidos: Crisis republicana

La marcha hacia el abismo

Diez años después, se desarrolla un ‘argentinazo’ mundial

Crisis y alternativas

Una gran epopeya cubana (I)

Los republicanos divididos, los ciudadanos unidos

Un listado poco difundido

En Perú hay un peligro grave para América Latina

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

Diamond Comic Distributors Announces Change in Acquisition Partners

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

Diamond Comic Distributors Announces Change in Acquisition Partners

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

Diamond Comic Distributors Announces Change in Acquisition Partners

CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles